1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Opinion on Olivier G?

Discussion in 'Takeda IT' started by l00ptruy, May 8, 2016 at 12:24 AM.

  1. l00ptruy

    l00ptruy new user

    Joined:
    May 7, 2016
    Messages:
    2
    Likes Received:
    0
    what do you guys, think? Doing a good job? will last long or not so long?
     

  2. anonymous

    anonymous Guest

    OG would have been a good CIO in the 1990s. i heard that's where a McK study ranked takeda for ISIT infrastructure...now we only have 30 years to catch up on. and his leadership teams meet face to face monthly costing the company at least $80k in travel. way to go OG